Trk Receptors

Trk receptor inhibitors act on tropomyosin receptor kinases (Trk), the receptor tyrosine kinases for neurotrophins. Tropomyosin receptor kinases A, B and C (TrkA, TrkB, TrkC) are encoded by the neurotrophic receptor tyrosine kinase genes (NTRK1, NTRK2, NTRK3). In 1991 TrkA was identified as a signal-transducing receptor for nerve growth factor (NGF). In the same year TrkB was shown to bind brain-derived neurotrophic factor (BDNF) and neurotrophin-3. The receptors support neuronal survival and synaptic plasticity, and NTRK1-3 gene fusions are studied in several tumor types. Entrectinib inhibits all three Trk receptors together with c-ros oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK). AZ 23 targets TrkA and TrkB, whereas ANA-12 is a TrkB inhibitor used to probe BDNF signaling.

4 Items

  • LM11A-31 HCl
    Cat. No.
    A22564

    LM11A-31 HCl

    Synonyms: LM11A-31 hydrochloride; LM11A-31

    LM11A-31 is a small-molecule p75NTR modulator and proNGF antagonist.

    5 mg
    $20.00
    10 mg
    $30.00
    All 7 sizes
  • IGF-1R modulator 1
    Cat. No.
    A28700

    IGF-1R modulator 1

    IGF-1R modulator 1 is a selective modulator of the insulin-like growth factor 1 receptor (IGF-1R), exhibiting EC50 values of 0.25 μM for IGF-1R, alongside notable activity against FGFR1, TrkA, and TrkB. This compound is valuable in the study of pathological conditions associated with dysregulated signaling of neurotrophins and trophic factors, including Alzheimer's disease. Its efficacy in modulating IGF-1R offers potential insights into therapeutic approaches for neurodegenerative disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PTX-BD10-2
    Cat. No.
    A34999

    PTX-BD10-2

    Synonyms: BD10-2

    PTX-BD10-2 is an orally active modulator of TrkB/C that demonstrates protective effects against basal forebrain cholinergic neuron (BFCN) degeneration. This compound has been shown to restore cholinergic neurite integrity and alleviate cholinergic neurite atrophy. PTX-BD10-2 serves as a valuable tool in research focused on Alzheimer's disease and related neurodegenerative disorders.

    Out of stock

    All 3 sizes
  • (Rac)-LM11A-31 dihydrochloride
    Cat. No.
    B10833

    (Rac)-LM11A-31 dihydrochloride

    (Rac)-LM11A-31 dihydrochloride is an isomer of the LM11A-31 compound, functioning as a non-peptide modulator targeting the p75 neurotrophin receptor (p75NTR). This compound exhibits potent antagonistic activity against proNGF (nerve growth factor), making it valuable for research in neurodegenerative diseases and neurobiology. Its oral bioavailability and efficacy position it as a useful tool in studying the role of nerve growth factors in various cellular processes.

    5 mg
    $40.00
    10 mg
    $60.00
    All 2 sizes

4 Items

Added to your cart

View Cart Checkout

    Loading...